However, reduced numbers of CD19+ cells (212 [154.5-260] CD19+ cells/10,000 PBMCs) were also found in untreated MM patients highlighting quantitative B cell defects prior to any treatment (data not shown) (19). This evidence concerns the gene CD19 and Miyoshi myopathy.